• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生殖细胞肿瘤中与肝功能障碍相关的甲胎蛋白假升高。

False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.

作者信息

Germà J R, Llanos M, Tabernero J M, Mora J

机构信息

Unidad de Oncologia Médica, Hospital de La Santa Creu i Sant Pau, Universidad Autonoma de Barcelona, Spain.

出版信息

Cancer. 1993 Oct 15;72(8):2491-4. doi: 10.1002/1097-0142(19931015)72:8<2491::aid-cncr2820720829>3.0.co;2-0.

DOI:10.1002/1097-0142(19931015)72:8<2491::aid-cncr2820720829>3.0.co;2-0
PMID:7691391
Abstract

BACKGROUND

Determination of serum concentration human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) is crucial in diagnosis, prognosis, treatment, and follow-up of patients with germ cell tumors. Elevation of these markers almost indicates progression or recurrence of the germ cell tumor. However, an increase in these tumor markers can be produced by several benign causes.

METHODS

The authors report nine cases of gonadal germ cell tumors that had increased serum levels of AFP without tumoral progression, recurrence, or residual tumor.

RESULTS

The AFP elevations were attributed to liver damage secondary to drugs (chemotherapy, anesthetics, or antiepileptics), virus, or alcoholism. No clinical evidence (or in some cases surgical evidence) of malignant tumor activity was found in any of the patients.

CONCLUSIONS

The elevation of serum levels of AFP in patients with germ cell tumors can be produced by liver dysfunction. These elevations must be interpreted with caution to avoid unnecessary treatments.

摘要

背景

血清人绒毛膜促性腺激素(HCG)和甲胎蛋白(AFP)的测定对于生殖细胞肿瘤患者的诊断、预后、治疗及随访至关重要。这些标志物的升高几乎提示生殖细胞肿瘤进展或复发。然而,多种良性原因也可导致这些肿瘤标志物升高。

方法

作者报告了9例性腺生殖细胞肿瘤患者,其血清AFP水平升高,但无肿瘤进展、复发或残留肿瘤。

结果

AFP升高归因于药物(化疗药、麻醉药或抗癫痫药)、病毒或酒精中毒继发的肝损伤。所有患者均未发现恶性肿瘤活动的临床证据(某些病例为手术证据)。

结论

生殖细胞肿瘤患者血清AFP水平升高可能由肝功能障碍引起。必须谨慎解读这些升高情况,以避免不必要的治疗。

相似文献

1
False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.生殖细胞肿瘤中与肝功能障碍相关的甲胎蛋白假升高。
Cancer. 1993 Oct 15;72(8):2491-4. doi: 10.1002/1097-0142(19931015)72:8<2491::aid-cncr2820720829>3.0.co;2-0.
2
Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.术前甲胎蛋白升高在化疗后播散性生殖细胞肿瘤残留肿瘤切除中的意义。
J Surg Oncol. 2006 Dec 1;94(7):619-23. doi: 10.1002/jso.20418.
3
The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.甲胎蛋白在恶性畸胎瘤及相关性腺肿瘤患者血清中的意义。
Ann Clin Lab Sci. 1974 Jul-Aug;4(4):267-75.
4
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.持续性升高的甲胎蛋白与恶性卵巢生殖细胞肿瘤化疗期间的慢性乙型肝炎相关:病例系列及文献复习。
J Ovarian Res. 2019 Dec 13;12(1):124. doi: 10.1186/s13048-019-0598-x.
5
Serum AFP, hCG and CEA in the management of patients with testicular, ovarian and extragonadal germ cell tumors.血清甲胎蛋白、人绒毛膜促性腺激素及癌胚抗原在睾丸、卵巢和性腺外生殖细胞肿瘤患者管理中的应用
Int J Biol Markers. 1992 Apr-Jun;7(2):80-6. doi: 10.1177/172460089200700202.
6
Pure Testicular Seminoma with Non-Pathologic Elevation of Alpha Fetoprotein: A Case Series.伴有甲胎蛋白非病理性升高的纯睾丸精原细胞瘤:病例系列
Urol Int. 2017;99(3):353-357. doi: 10.1159/000478706. Epub 2017 Jul 1.
7
Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage.甲胎蛋白-凝集素结合作为肿瘤活性或肝损伤的标志物
Eur J Cancer. 1990;26(9):969-72. doi: 10.1016/0277-5379(90)90622-z.
8
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.青少年睾丸微石症伴生殖细胞肿瘤:对未来管理的关注。
Urology. 2013 Aug;82(2):454-7. doi: 10.1016/j.urology.2013.02.011. Epub 2013 Apr 6.
9
Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.甲胎蛋白升高的组织学纯精原细胞瘤:10例临床病理研究
Oncol Rep. 1998 Nov-Dec;5(6):1425-9. doi: 10.3892/or.5.6.1425.
10
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.采用间接免疫过氧化物酶技术对睾丸生殖细胞肿瘤中甲胎蛋白和人绒毛膜促性腺激素进行细胞定位。
Cancer. 1977 Nov;40(5):2136-51. doi: 10.1002/1097-0142(197711)40:5<2136::aid-cncr2820400524>3.0.co;2-d.

引用本文的文献

1
Serum tumour markers for testicular cancer recurrence.用于睾丸癌复发的血清肿瘤标志物。
Nat Rev Urol. 2023 Aug;20(8):459-460. doi: 10.1038/s41585-023-00782-7.
2
Improving outcomes in germ cell cancers using miRNA.利用微小RNA改善生殖细胞癌的治疗效果。
Ther Adv Med Oncol. 2021 Jun 30;13:17588359211027826. doi: 10.1177/17588359211027826. eCollection 2021.
3
Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions.液体活检在生殖细胞肿瘤患者临床管理中的应用:现状与未来方向。
Int J Mol Sci. 2021 Mar 6;22(5):2654. doi: 10.3390/ijms22052654.
4
MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.微小RNA作为睾丸生殖细胞肿瘤患者非特异性甲胎蛋白(AFP)升高的合适鉴别指标
Noncoding RNA. 2020 Jan 1;6(1):2. doi: 10.3390/ncrna6010002.
5
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.持续性升高的甲胎蛋白与恶性卵巢生殖细胞肿瘤化疗期间的慢性乙型肝炎相关:病例系列及文献复习。
J Ovarian Res. 2019 Dec 13;12(1):124. doi: 10.1186/s13048-019-0598-x.
6
State-of-the-Art Management of Germ Cell Tumors.生殖细胞肿瘤的最新管理
Am Soc Clin Oncol Educ Book. 2018 May 23;38:319-323. doi: 10.1200/EDBK_201139.
7
The present and future of serum diagnostic tests for testicular germ cell tumours.血清诊断检测在睾丸生殖细胞肿瘤中的现状与未来。
Nat Rev Urol. 2016 Dec;13(12):715-725. doi: 10.1038/nrurol.2016.170. Epub 2016 Oct 18.
8
Recurrent ovarian endodermal sinus tumor: demonstration by computed tomography, magnetic resonance imaging, and positron emission tomography.
Eur J Nucl Med. 1995 Oct;22(10):1214-7. doi: 10.1007/BF00800608.